Tasca Therapeutics
PrivateLast Round
Series A
Sep 16, 2025
Total Funding Raised
$119M
Momentum Score
50 /100
Company Overview
Tasca Therapeutics is a biotechnology company that develops small molecule drugs for hard-to-treat oncology indications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tasca Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Tasca Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2025 | ||||
| Series A | Dec 10, 2024 |
Tasca Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 8VC | Series A |
| Cure Ventures | Series A |
| Invus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 24% QoQ from 17 to 21 employees.
- Apr 25, 2026
Grew 25% QoQ, from 16 to 20 employees.
Tasca Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tasca Therapeutics's valuation, stock price, and market status.
